BIOACAPAN

BSMA

Bioactive implantable capsule for pancreatic islet immunosuppression free therapy 

Coordinator : Dr. Florence Rivera (CEA-LETI, Grenoble, France)
UCL promotors : Karine Glinel, Alain Jonas (BSMA)

In BIOCAPAN we aim at developing an innovative treatment for Diabetes Mellitus, based on the implantation of smartly microencapsulated allogeneic islet cells, which will allow an effective long-lasting blood glucose normalization and stabilisation, without the need for immunosuppressants.

www.biocapan.eu